References
Shaw HM, Milton GW, Farago G, McCarthy WH (1978) Endocrine influences on survival from malignant melanoma. Cancer 42:669–677
Rampen FHJ (1982) Malignant melanoma: Prognostic factors. Thesis, Amsterdam
Rampen FHJ (1980) Malignant melanoma: Sex differences in survival after evidence of distant metastases. Br J Cancer 42: 52–57
Rampen FHJ, Mulder JH (1980) Malignant melanoma: An androgen-dependent tumour? Lancet I:562–565
Creagan ET, Ingle JN, Green SJ, Ahmann DL, Jiang N-S (1980) Phase II study of tamoxifen in patients with disseminated malignant melanoma. Cancer Treat Rep 64:199–201
Creagan ET, Ingle JN, Ahmann DL, Green SJ (1982) Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma. Cancer 49:1353–1354
Herbst WP (1943) Malignant melanoma of the choroid with extensive metastases treated by removing secreting tissue of the testicles. JAMA 122:597
Flax H, Salih H, Westbury G (1973) Hormone therapy in malignant melanoma. Lancet II:147
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rampen, F.H.J. Comments on the contribution by H. J. Grill et al.. Arch Dermatol Res 275, 208–209 (1983). https://doi.org/10.1007/BF00510057
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00510057